Carregant...
RAD6 promotes chemoresistance in ovarian cancer
Mortality in ovarian cancer is predominantly due to acquired chemoresistance and tumor recurrence. UBIQUITIN CONJUGATING ENZYME E2 or RAD6 expression increases in cell lines and patient tumors in response to platinum-based chemotherapy and promotes both activation of DNA damage response pathways and...
Guardat en:
| Publicat a: | Mol Cell Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791863/ https://ncbi.nlm.nih.gov/pubmed/29404391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1392403 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|